HCA Healthcare Q1 EPS rises 10.9% to $7.15; 2026 guidance reaffirmed
HCA Healthcare reported first-quarter 2026 revenues of $19.109 billion, up 4.3%, and diluted earnings per share of $7.15, up 10.9% from $6.45 a year earlier. The company reaffirmed its 2026 guidance and declared a quarterly dividend of $0.78 per share, payable June 30, 2026.
Key points
- Revenues rose 4.3% to $19.109 billion; net income attributable to HCA Healthcare was $1.620 billion, up 0.6%.
- Adjusted EBITDA rose 1.9% to $3.802 billion, though its margin fell to 19.9% from 20.4%.
- Respiratory-related admissions fell 42%, and a January winter storm hurt volumes; Medicaid supplemental programs not in initial guidance offset much of the impact.
- Guidance reaffirmed for 2026, including diluted EPS of $29.10 to $31.50; the company repurchased 3.157 million shares for $1.571 billion in the quarter.
The filing
Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.